Inhibitors of protein synthesis inhibit both La Crosse virus S-mRNA and S genome syntheses in vivo
- PMID: 3751285
- DOI: 10.1016/0168-1702(86)90061-4
Inhibitors of protein synthesis inhibit both La Crosse virus S-mRNA and S genome syntheses in vivo
Abstract
The effect of drugs such as puromycin and cycloheximide, which inhibit protein synthesis, on the accumulation of La Crosse virus S genome RNAs in vivo has been examined. We have found that if these drugs are added to the cultures before infection, minuscule amounts of S-mRNA can be detected late in infection. Genome replication, on the other hand, cannot be detected at any time. When these drugs are added later in infection when RNA synthesis is well established, S-mRNA accumulation decreases in a dose-dependent manner proportional to the effect of these drugs on protein synthesis. This decrease cannot be accounted for by increased turnover of the mRNA in the presence of the drug. S genome replication, curiously, was found to be hypersensitive to the effects of these drugs. Our results confirm those of Abraham and Pattnaik (1983) that ongoing protein synthesis is required for the accumulation of complete bunyavirus S-mRNA.
Similar articles
-
Translational requirement for La Crosse virus S-mRNA synthesis: a possible mechanism.J Virol. 1987 Dec;61(12):3960-7. doi: 10.1128/JVI.61.12.3960-3967.1987. J Virol. 1987. PMID: 3682062 Free PMC article.
-
Characterization of La Crosse virus small-genome transcripts.J Virol. 1984 Mar;49(3):680-5. doi: 10.1128/JVI.49.3.680-685.1984. J Virol. 1984. PMID: 6321757 Free PMC article.
-
La Crosse virus small genome mRNA is made in the cytoplasm.J Virol. 1986 May;58(2):647-50. doi: 10.1128/JVI.58.2.647-650.1986. J Virol. 1986. PMID: 3701924 Free PMC article.
-
Genetic determinants of the virulence and infectivity of La Crosse virus.Microb Pathog. 1988 Jan;4(1):1-7. doi: 10.1016/0882-4010(88)90041-1. Microb Pathog. 1988. PMID: 3059135 Review. No abstract available.
-
Coding assignments of the RNA genome segments of California serogroup viruses.Prog Clin Biol Res. 1983;123:107-17. Prog Clin Biol Res. 1983. PMID: 6346335 Review. No abstract available.
Cited by
-
Translational requirement of La Crosse virus S-mRNA synthesis: in vivo studies.J Virol. 1987 Jan;61(1):96-103. doi: 10.1128/JVI.61.1.96-103.1987. J Virol. 1987. PMID: 3783827 Free PMC article.
-
Germiston virus transcriptase requires active 40S ribosomal subunits and utilizes capped cellular RNAs.J Virol. 1992 Feb;66(2):685-93. doi: 10.1128/JVI.66.2.685-693.1992. J Virol. 1992. PMID: 1731108 Free PMC article.
-
Characterization of the Interaction between hantavirus nucleocapsid protein (N) and ribosomal protein S19 (RPS19).J Biol Chem. 2011 Apr 1;286(13):11814-24. doi: 10.1074/jbc.M110.210179. Epub 2011 Feb 4. J Biol Chem. 2011. PMID: 21296889 Free PMC article.
-
Targeting a Novel RNA-Protein Interaction for Therapeutic Intervention of Hantavirus Disease.J Biol Chem. 2016 Nov 18;291(47):24702-24714. doi: 10.1074/jbc.M116.750729. Epub 2016 Oct 12. J Biol Chem. 2016. PMID: 27733686 Free PMC article.
-
Unusual transcripts in La Crosse virus-infected cells and the site for nucleocapsid assembly.J Virol. 1987 Mar;61(3):667-72. doi: 10.1128/JVI.61.3.667-672.1987. J Virol. 1987. PMID: 3806796 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources